ARCHIVES

Dana-Farber, Harvard And Affiliates Form Cancer Center.

This article is from The Cancer Letter archive.

Vol. 26 No. 05 | February 4, 2000

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Takes Summer Publication Break.

August 2, 2002

ASTRO Members Approve Governance, Dues Changes

January 17, 2003

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

For Frederick, Unseat Program Resources Inc.

March 3, 1995

Three New RFAs Announced In Cancer Control

November 3, 1978

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012